跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,414 条关于
“oral candidiasis”
全部
28,414
临床试验
21,620
药物
1,219
机构
83
资讯
5,492
去年
FDA Approves Bimekizumab (Bimzelx) for Psoriatic Arthritis and Axial Spondyloarthritis
去年
FDA Approves Single-Injection 320 mg BIMZELX® for Plaque Psoriasis and Psoriatic Arthritis
去年
Basilea's Fosmanogepix Enters Phase 3 for Invasive Candidiasis Treatment
5年前
UCB Announces U.S. FDA Approvals for BIMZELX® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
10个月前
Eupraxia's EP-104GI Shows Sustained Clinical Remission in Eosinophilic Esophagitis Patients at 52 Weeks
去年
FDA Approves Bimzelx for Moderate-to-Severe Hidradenitis Suppurativa
去年
Bimekizumab Shows Efficacy and Safety in Elderly Psoriasis Patients
去年
Bimzelx Approved by FDA as First IL-17A and IL-17F Inhibitor for Hidradenitis Suppurativa
去年
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate to Severe Hidradenitis Suppurativa
去年
Bimekizumab Approved by FDA for Moderate to Severe Hidradenitis Suppurativa
第 1 页,共 550 页
上一页
下一页